May 18, 2020 / 12:40 PM / 15 days ago

BRIEF-FDA Clears Application For Phase II Trial Of Viralclear’S Merimepodib To Treat Covid-19

May 18 (Reuters) - Biosig Technologies Inc:

* FDA CLEARS THE INVESTIGATIONAL NEW DRUG APPLICATION TO ENABLE THE PHASE II TRIAL OF VIRALCLEAR’S MERIMEPODIB, ORAL SOLUTION TO TREAT ADULT PATIENTS WITH ADVANCED COVID-19, TO PROCEED

* BIOSIG TECHNOLOGIES INC - PHASE II CLINICAL TRIAL EXPECTED TO BE CONDUCTED AT MULTIPLE CENTERS IN UNITED STATES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below